Skip to main content

Articles

Practice Management
Building Your Automated Bundled Payment for an Episode-of-Care Initiative
Read More
FDA Approvals
Drugs in Phase 3 Clinical Trials for Type 2 Diabetes
Read More
Conference Highlights ADA
Cutting-Edge Data Presented at ADA 2011 Highlight the Diabetes–Cardiovascular Disease Link
Read More
Introduction
In Search of Stakeholder Collaboration to Stem the Cardiometabolic Epidemic
Read More
Original Research
Obesity in the Workplace: Impact on Cardiovascular Disease, Cost, and Utilization of Care
Stakeholder Perspective
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
Read More
Original Research
A Call to Action: Responding to the Future Forecasting of Cardiovascular Disease in America
Stakeholder Perspective
Prevention Efforts before Disease Strikes the Key to a Healthy Population of Young Adults
Read More
Original Research
Atypical Antipsychotics and Metabolic Syndrome in Patients with Schizophrenia: Risk Factors, Monitoring, and Healthcare Implications
Stakeholder Perspective
The Complexities of Treating Mental Illness
Read More
Original Research
Current Therapies and Emerging Drugs in the Pipeline for Type 2 Diabetes
Stakeholder Perspective
New Therapies with Novel Mechanisms of Action Are Urgently Needed for Type 2 Diabetes
Read More
Original Research
Lipid Management in Patients with Type 2 Diabetes
Stakeholder Perspective
The Time Is Now to Promote Aggressive Lipid Management to Prevent Macrovascular Complications in Patients with Type 2 Diabetes
Read More
Can Episode Payments Reduce Cost and Maintain Quality Cancer Care?
Read More
Page 213 of 244
Results 2121 - 2130 of 2434